In this report from Spain, GPi-DBS in 10 children/adolescents with SGCE-rlated Myoclonus Dystonia led to significant improvement in myoclonus (68.1%), generalized dystonia (63.2%), and dystonia during writing (48.1%), walking (70.3%) and running (44.2%).

@movedisorder.

Generate videos in just a few seconds. Try Grok Imagine, free for a limited time.

Measuring fronto-striatal function to rate mild cognitive impairment versus dementia requires the right clinical outcome assessment. The COA tests recommended by an MDS expert panel have psychometric qualities that enable improved PD diagnosis and research.

A major finding from Kishore et al.’s study of 7,918 PD patients in India: the average age at onset (~54 years) is significantly younger than that reported in Western populations.

Because the true carrier frequency of ataxia-causing genes and degree of reduced penetrance are likely underestimated by the current MDSGene dataset, improving access to genetic testing in underserved regions globally should be prioritized. @movedisorder.

How common are sleep disorders in patients with RFC1-spectrum disorders? In the following study, Funcis and colleagues highlight that they are exceedingly common, with obstructive sleep apnea (OSA) being the most frequent.

Interesting work by Prof. Taira and colleagues: unilateral FUS pallidothalamic tractotomy (PTT) in Parkinson’s disease showed short-term improvement in bilateral wearing-off and dyskinesia. It is presumably due to bilateral projections of the PTT.

In this review article, the authors highlight the distinct neuroanatomical and temporal dynamics of the non-motor aspects of PD and explore the possibility of developing adaptive DBS for non-motor symptoms. A "must-read" article for DBS-enthusiasts!

Since clozapine is a highly effective antipsychotic for Parkinson’s disease-associated psychosis, this policy change could help expand access to a treatment that has long been underutilized in PD.

In this insightful viewpoint article, the authors discuss the impact of the recent FDA decision to end the requirement for blood monitoring in clozapine use.

Exciting results from Yska et al.: Hematopoietic stem cell transplantation halted disease progression in CSF1R-related disorder after 6 months post-transplantation, with impressive clinical and radiological improvements at a median follow-up of 2.5 years.

Note: Heterozygous ELOVL5 variants have been associated with spinocerebellar ataxia 38 (SCA 38) a disorder characterized by adult onset progressive ataxia, dysarthria, and nystagmus.

The triad of hypomyelinating leukodystrophy, ichthyosis, and a movement disorder appears to be unique to ELOVL1-related disorders.

An important study by Wong et al. on neuro-ichthyosis linked .to biallelic ELOVL1 variants. In this hypomyelinating leukodystrophy, commonly observed abnormal movements included spasticity, head tremor, and myoclonus.

@muthu100680 Key finding: In PD patients with camptocormia, there is heightened central muscle drive to the paravertebral lumbar muscles.".

"This intriguing study by @muthu100680's team explores abnormalities in the central motor network among Parkinson’s disease patients with camptocormia.

Could altered D1/D3 receptor dynamics be driving RLS and its augmentation? Clemens et al. explore this compelling angle in a thought-provoking viewpoint article. A "must-read" piece for RLS-enthusiasts!

Wrigley et al. report clinicopathologic insights into PSP and its .mimics: 83.5% (197/241) of autopsy-confirmed PSP cases had the correct clinical diagnosis. Most common mimics? Lewy body diseases, CBD, and MSA.

No significant benefit of transcutaneous tibial nerve stimulation (1 Hz via Geko device) for overactive bladder in Parkinson’s disease, per phase II STRIPE trial. Maybe 1 Hz isn’t the sweet spot, and it’s worth exploring other settings/devices!

Does CBD have a prodromal phase? Still an open question, but a fascinating case by Tai et al. showed progressive, asymmetric parietal atrophy on serial MRIs spanning a decade before the clinical diagnosis was made!